New stroke risk reduction technology designed to advance procedural performance and safety, treat wider range of patients with non-valvular atrial fibrillation MARLBOROUGH, Mass., July 21, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) announced it has received U.S. Food and Drug Administration (FDA) approval for the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device. Experience […]
Coronary/Structural Heart
RealView Imaging Ltd., the World Leader in Medical Holography, Completes its $10M Series C Funding Round
YOKNEAM, Israel, July 22, 2020 /PRNewswire/ — RealView Imaging Ltd. today announced the completion of its $10M series C financing round. New investors in this round include OurCrowd, a major hi-tech venture capital fund, Judith and Kobi Richter, among the most prominent technology and medical Israeli entrepreneurs, as well as other notable investors and leading physicians. The majority […]
Eko Awarded $2.7 Million SBIR Grant from NIH to Advance Clinical Study on Valvular Heart Disease Detection Using AI and Digital Stethoscope
Ongoing research with Northwestern Medicine to validate algorithms and help more accurately screen for heart murmurs and valvular heart disease during routine office visits OAKLAND, Calif.–(BUSINESS WIRE)–Eko today announced that it has been awarded a $2.7 million Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH). The […]
MemorialCare Long Beach Medical Center One of Only Three Southern California Hospitals to be Named Robotic-Assisted Thoracic Surgery Case Observation Site
LONG BEACH, Calif., July 21, 2020 /PRNewswire/ — Intuitive Surgical® has named MemorialCare Long Beach Medical Center as a Mentor Case Observation Site for robotic-assisted thoracic surgery using the da Vinci® Xi™ Surgical System. The designation of a case observation site means that at Long Beach Medical Center there is an expert surgeon, Amir Abolhoda, M.D., to […]
XyloCor Therapeutics Doses Patients in Phase 1/2 Trial Evaluating Novel Gene Therapy XC001 in Refractory Angina
– Novel gene therapy designed to stimulate formation of new coronary blood vessels is being studied in patients with treatment-resistant angina with no remaining treatment options – July 21, 2020 07:00 AM Eastern Daylight Time MALVERN, Pa.–(BUSINESS WIRE)–XyloCor Therapeutics today announced it has successfully dosed the first two patients in […]
Paragonix Technologies Receives Coveted International Design Award for Novel Organ Transportation System
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. today announced that its flagship product, Paragonix SherpaPak™ Cardiac Transport System (CTS), is the recipient of a prestigious international design award: the Red Dot Award. The traditional mechanism by which organs are transported (bagged on ice in a consumer cooler) has remained unchanged for more than […]
LivaNova announces the commercial launch of the Perceval Plus aortic valve in Europe
Next generation sutureless surgical technology is based on a clinically proven platform and has been designed to provide valve durability LONDON – ( BUSINESS WIRE ) – LivaNova PLC (NASDAQ: LIVN), a leading medical technology and innovation company, announced today that the Perceval ® Plus Advanced Suture-Free Surgical Aortic Valve is now available for a commercial […]
Canon Medical Introduces New Configuration of Aquilion ONE / GENESIS Edition – A Comprehensive Cardiac CT Solution Powered by Artificial Intelligence
New System Rounds Out CT Portfolio that Provides Clinicians with Innovative Cardiac Capabilities TUSTIN, Calif.–(BUSINESS WIRE)–To meet the growing cardiovascular imaging needs of healthcare systems, Canon Medical Systems USA, Inc. is introducing a new configuration of the Aquilion ONE / GENESIS Edition – the Aquilion ONE / GENESIS SP – a complete […]
PhaseBio Doses First Patient in VANGARD Phase 2 Clinical Trial to Evaluate PB1046 for Hospitalized COVID-19 Patients
Recently launched Phase 2 “VANGARD” trial to assess the efficacy and safety of PB1046 in hospitalized COVID-19 patients at high risk for rapid clinical deterioration and acute respiratory distress syndrome PB1046, a long-acting analog of vasoactive intestinal peptide (VIP), has the potential to modulate several proinflammatory cytokines that are believed […]
DAXOR ANNOUNCES PROSPECTIVE RANDOMIZED CONTROL TRIAL AT DUKE UNIVERSITY MEDICAL CENTER TO GUIDE VOLUME TREATMENT IN HEART FAILURE PATIENTS
Enrollment Commences Using the BVA-100® Diagnostic Blood Test NEW YORK, July 16, 2020 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced the initiation of a prospective randomized control trial (RTC) utilizing Daxor’s BVA-100 (Blood […]



